Navigation Links
NuvaRing Blood-Clotting Lawsuit Help: Resource4thePeople Reports Number of Cases in Consolidated Federal Litigation Increases
Date:9/9/2013

San Diego, CA (PRWEB) September 09, 2013

http://www.resource4thepeople.com/defectivedrugs/nuvaring.html

Resource4thePeople announced today that there have been several new developments of interest to consumers who are following the progress of lawsuits alleging that women who used the popular contraceptive NuvaRing suffered serious blood-clotting problems.

Federal court officials, in their latest reporting data, say that the number of NuvaRing cases from across the country that have been consolidated before a U.S. District Court judge in Missouri over similar claims of blood-clotting problems has increased to 1,279.*

“These figures were reported as of Aug. 15, 2013 by the U.S. Judicial Panel for Multidistrict Litigation and if the number of inquiries we have received from women who have also been affected by similar allegations is any indication this number will probably continue to climb,” said Resource4thePeople.

“As a result we will continue our offer of free consultations to women who may have been affected by problems that allegedly were caused by their use of the NuvaRing IUD and are seeking information about their legal options to seek compensation for medical costs and other expenses they may have incurred.”

The 1,279 cases being overseen by U.S. District Judge Rodney Sippel in the Eastern District of Missouri involve common allegations that are summed up on the court’s multidistrict litigation web site and include the following language:

“NuvaRing is a prescription contraceptive device used by women throughout the United States. The individual plaintiffs in this matter claim that use of NuvaRing caused them injuries. They have filed suit in several state and federal courts alleging that the manufacturer of NuvaRing failed to adequately warn of the risks associated with the use of the product, and/or that the NuvaRing product is otherwise defective and unreasonably dangerous.”**

The first bellwether trial from this pool of federal lawsuits involving claims that the NuvaRing puts women at higher risk of suffering blood clots than other contraceptives is scheduled to begin in October.

Judge Sippel recently made an important ruling in the litigation, finding that the woman seeking damages in the bellwether trial will be able to seek punitive damages under the provisions of Missouri law, according to a July 12, 2013 opinion in the court file. The defendants had sought to have the case tried under more restrictive New Jersey law.

As this litigation progresses, other NuvaRing lawsuits continue to be filed, including one by lawyers for a California woman who, according to the complaint*** she filed in U.S. District Court in New Jersey, attributes a serious blood-clotting problem to her use of the NuvaRing contraceptive.

"This lawsuit is among hundreds of others in which women claim that the manufacturers of the NuvaRing vaginal ring contraceptive has caused them to suffer life-threatening blood-clotting problems," said Resource4thePeople.

The California woman's lawsuit also alleges that the manufacturers of the contraceptive were aware that the NuvaRing put women at greater risk of suffering blood clots but failed to adequately inform consumers and government regulators.

Another such case**** was recently filed by a Louisiana woman who claims she suffered a pulmonary embolism as a result of her use of the NuvaRing IUD. The case was filed in U.S. District Court New Jersey and names Organon, USA, Inc. and Merck & Co, Inc. as defendants.

In addition to seeking damages for her medical expenses and other costs, the woman is seeking other damages against the defendants over allegations that they were aware of dangerous side effects from the use of the NuvaRing IUD but were negligent in failing to warn consumers and health care professionals, according to the court file.

The defendants “falsely marketed NuvaRing as a safe and effective contraceptive without alerting women to the serious risk of developing blood clots, deep vein thrombosis and/or pulmonary embolism,” according to the woman’s allegations in the court file.

Resource4thePeople said the progress of this litigation does not bar other women from filing their own NuvaRing lawsuits alleging serious, life-threatening blood-clotting problems and consumers will continue to be updated about key developments in the lawsuits.

In addition to the federal consolidated lawsuits, over 200 such state court cases are under the supervision of a judge in New Jersey Superior Court, where another multidistrict litigation***** is underway.

Named as defendants in these litigations are Organon Pharmaceuticals USA Inc., Organon International Inc. and Schering-Plough Corp., who, according to the court file, allegedly falsely marketed and sold the NuvaRing as a safe, efficient alternative to birth control pills.

The NuvaRing was approved by the Food and Drug Administration in 2001 after being created by Organon as a flexible IUD, or ring, hence the name. The IUD releases a low dose of etonogestrel and estrogen over three weeks, providing women the flexibility of a monthly contraceptive.

On Oct. 27, 2011 the FDA released the findings of government research that put women who used the NuvaRing or other IUDs with a similar mixture of hormones at a 56 percent higher risk of suffering blood clotting that led to deep vein thrombosis and pulmonary embolisms than women on birth control pills.******

Resource4thePeople also notes that NuvaRing has now posted a warning about the increased risks of suffering blood clots on the company’s web site under the heading of “IMPORTANT SAFETY INFORMATION."*******

Sources:
*http://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL-Dockets_By_District-August-15-2013.pdf
**In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, U.S. District Court, Eastern District of Missouri
***Case # 2:2013cv04195, United States District Court for the District of New Jersey
**** Case # 2:13-cv-2933, U.S. District Court for New Jersey
***** In Re NuvaRing Litigation, Docket No. BER-L-3081-09, Bergen County, New Jersey Superior Court
******http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf FDA Oct. 27, 2011
*******http://www.nuvaring.com/Consumer/index.asp

Read the full story at http://www.prweb.com/releases/2013/9/prweb11091505.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Law Firm Aggressively Litigating against Birth Control Makers for their Newer, but Allegedly Unsafer Products: Nuvaring, Yaz, BeYaz, Yasmin, Ocella, Gianvi
2. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
3. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
4. NuvaRing Blood-Clotting Victims Still Eligible to File Lawsuits Through Resource4thePeople
5. NuvaRing Lawsuit Filed on Behalf of a South Carolina Woman who Developed Two Blood Clots While Using NuvaRing, Reports Wright & Schulte LLC
6. Federal NuvaRing Blood-Clotting Lawsuits Report: Resource4thePeople Updates Consumers with News That First Bellwether Trial Rescheduled to July
7. NuvaRing Blood-Clotting Claims Now Being Investigated by Resource4thePeople Attorneys
8. DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
9. 2013 NuvaRing Blood-Clotting Allegations Inquiries Eligible for Review by Resource4thePeople Attorneys
10. Rescheduling of First NuvaRing Lawsuit Trials in State, Federal NuvaRing Lawsuit Litigation, Reports Wright & Schulte LLC
11. First NuvaRing Lawsuits in State, Federal NuvaRing Litigations Set to Head to Trial Later This Year, Alonso Krangle LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... A ... Safety Congress and Expo event March 9-11, 2016. Hosted by Ohio's Bureau of ... , As the longest running and largest worker's compensation event in Ohio, ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... Everseat digital self-scheduling readily available to physicians. The integration will enable Allscripts ... and select appointments via Everseat’s free mobile app. , The partnership gives Everseat ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... Jacksonville, FL 32224, February 26th: Amateur & Professional Divisions - Time: 7:00pm ... 7:00pm – 10:00pm | Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , ...
(Date:2/10/2016)... ... ... Workrite Ergonomics, who is celebrating their 25th year of business in 2016, is ... recognized leader in their industry. , "We are very proud of our heritage and ... “Workrite recognized the importance of good ergonomics before most of our competition even knew ...
(Date:2/10/2016)... ... 2016 , ... Anxiety of older Americans over steep cost increases of prescription ... decade ago, according to The Senior Citizens League (TSCL). Since last ... with rapidly rising costs. “The implications are chilling, particularly for people with chronic ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 2016 ALSP, Inc. announced that it has appointed ... Medical Affairs in preparation for its move into clinical trials ... CEO, stated, "We are pleased to welcome Dallas Hack ... with an individual of such practical knowledge and far-reaching experience ... deeply on his broad experience and success as a clinician ...
(Date:2/10/2016)... , Feb. 10, 2016 Intouch Solutions, a ... identified an industry-wide trend regarding the evolution of ... organizations to efficiently deliver compelling sales presentations via ... and another in 2015, Intouch uncovered that while ... devices and DSAs, many are not using them ...
(Date:2/10/2016)... 2016  Until recently, the options for reducing the ... the FDA approved the non-invasive Coolsculpting treatment, which removes ... originally approved in 2010 for the abdomen and this ... chin. With this add-on approval, the experts at Laser ... applicator, the CoolMini, to address smaller areas of fat. ...
Breaking Medicine Technology: